_id
691727b03c536f8df2316c29
Ticker
VAXX
Name
Vaxxinity Inc
Exchange
PINK
Address
505 Odyssey Way, Merritt Island, FL, United States, 32953
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.vaxxinity.com
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.
Last Close
0.0003
Volume
257
Current Price
0.0003
Change
0
Last Updated
2025-12-04T14:56:33.911Z
Image
https://logo.clearbit.com/www.vaxxinity.com
Ipo Date
2021-11-11T00:00:00.000Z
Market Cap
25356
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
15
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2024-03-31
Revenue
-
Cost Of Revenue
456000
Gross Profit
-456000
Operating Expenses
11194000
Operating Income
-11650000
Interest Expense
182000
Pretax Income
-11392000
Net Income
-11392000
Eps
-0.08954707667154019
Dividends Per Share
-
Shares Outstanding
112910552
Income Tax Expense
412188
EBITDA
-11194000
Operating Margin
-
Total Other Income Expense Net
258000
Cash
4931000
Short Term Investments
25464000
Receivables
414000
Inventories
-
Total Current Assets
33230000
Property Plant Equipment
11081000
Total Assets
44311000
Payables
1783000
Short Term Debt
1906000
Long Term Debt
-
Total Liabilities
30902000
Equity
13409000
Depreciation
456000
Change In Working Capital
-1670000
Cash From Operations
-11845000
Capital Expenditures
414000
Cash From Investing
-407000
Cash From Financing
-313000
Net Change In Cash
-12565000
PE
-
PB
0.0028462525169662164
ROE
-84.95786412111268
ROA
-25.709191848525197
FCF
-12259000
Fcf Percent
-
Piotroski FScore
0
Health Score
27
Deep Value Investing Score
5.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
8
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2024-03-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
456000
Quarters > 0 > income Statement > gross Profit
-456000
Quarters > 0 > income Statement > operating Expenses
11194000
Quarters > 0 > income Statement > operating Income
-11650000
Quarters > 0 > income Statement > interest Expense
182000
Quarters > 0 > income Statement > pretax Income
-11392000
Quarters > 0 > income Statement > net Income
-11392000
Quarters > 0 > income Statement > eps
-0.08954707667154019
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
127218000
Quarters > 0 > income Statement > income Tax Expense
412188
Quarters > 0 > income Statement > EBITDA
-11194000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
258000
Quarters > 0 > balance Sheet > cash
4931000
Quarters > 0 > balance Sheet > short Term Investments
25464000
Quarters > 0 > balance Sheet > receivables
414000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
33230000
Quarters > 0 > balance Sheet > property Plant Equipment
11081000
Quarters > 0 > balance Sheet > total Assets
44311000
Quarters > 0 > balance Sheet > payables
1783000
Quarters > 0 > balance Sheet > short Term Debt
1906000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
30902000
Quarters > 0 > balance Sheet > equity
13409000
Quarters > 0 > cash Flow > net Income
-11392000
Quarters > 0 > cash Flow > depreciation
456000
Quarters > 0 > cash Flow > change In Working Capital
-1670000
Quarters > 0 > cash Flow > cash From Operations
-11845000
Quarters > 0 > cash Flow > capital Expenditures
414000
Quarters > 0 > cash Flow > cash From Investing
-407000
Quarters > 0 > cash Flow > cash From Financing
-313000
Quarters > 0 > cash Flow > net Change In Cash
-12565000
Quarters > 0 > ratios > PE
-0.08954707667154019
Quarters > 0 > ratios > PB
0.0028462525169662164
Quarters > 0 > ratios > ROE
-84.95786412111268
Quarters > 0 > ratios > ROA
-25.709191848525197
Quarters > 0 > ratios > FCF
-12259000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2023-12-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
456000
Quarters > 1 > income Statement > gross Profit
-456000
Quarters > 1 > income Statement > operating Expenses
11194000
Quarters > 1 > income Statement > operating Income
-11650000
Quarters > 1 > income Statement > interest Expense
182000
Quarters > 1 > income Statement > pretax Income
-11392000
Quarters > 1 > income Statement > net Income
-11392000
Quarters > 1 > income Statement > eps
-0.08954707667154019
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
127218000
Quarters > 1 > income Statement > income Tax Expense
412188
Quarters > 1 > income Statement > EBITDA
-10754000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
258000
Quarters > 1 > balance Sheet > cash
4931000
Quarters > 1 > balance Sheet > short Term Investments
25464000
Quarters > 1 > balance Sheet > receivables
414000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
33230000
Quarters > 1 > balance Sheet > property Plant Equipment
11081000
Quarters > 1 > balance Sheet > total Assets
44311000
Quarters > 1 > balance Sheet > payables
1783000
Quarters > 1 > balance Sheet > short Term Debt
1906000
Quarters > 1 > balance Sheet > long Term Debt
13262000
Quarters > 1 > balance Sheet > total Liabilities
30902000
Quarters > 1 > balance Sheet > equity
13409000
Quarters > 1 > cash Flow > net Income
-11392000
Quarters > 1 > cash Flow > depreciation
456000
Quarters > 1 > cash Flow > change In Working Capital
-1670000
Quarters > 1 > cash Flow > cash From Operations
-11845000
Quarters > 1 > cash Flow > capital Expenditures
414000
Quarters > 1 > cash Flow > cash From Investing
-407000
Quarters > 1 > cash Flow > cash From Financing
-313000
Quarters > 1 > cash Flow > net Change In Cash
-12565000
Quarters > 1 > ratios > PE
-0.08954707667154019
Quarters > 1 > ratios > PB
0.0028462525169662164
Quarters > 1 > ratios > ROE
-84.95786412111268
Quarters > 1 > ratios > ROA
-25.709191848525197
Quarters > 1 > ratios > FCF
-12259000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2023-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
666000
Quarters > 2 > income Statement > gross Profit
-666000
Quarters > 2 > income Statement > operating Expenses
13445000
Quarters > 2 > income Statement > operating Income
-13445000
Quarters > 2 > income Statement > interest Expense
176000
Quarters > 2 > income Statement > pretax Income
-13145000
Quarters > 2 > income Statement > net Income
-13145000
Quarters > 2 > income Statement > eps
-0.10371890137278535
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
126736784
Quarters > 2 > income Statement > income Tax Expense
176000
Quarters > 2 > income Statement > EBITDA
-12303000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
300000
Quarters > 2 > balance Sheet > cash
17395000
Quarters > 2 > balance Sheet > short Term Investments
25124000
Quarters > 2 > balance Sheet > receivables
407000
Quarters > 2 > balance Sheet > inventories
206000
Quarters > 2 > balance Sheet > total Current Assets
46356000
Quarters > 2 > balance Sheet > property Plant Equipment
11123000
Quarters > 2 > balance Sheet > total Assets
57479000
Quarters > 2 > balance Sheet > payables
2974000
Quarters > 2 > balance Sheet > short Term Debt
1331000
Quarters > 2 > balance Sheet > long Term Debt
11977000
Quarters > 2 > balance Sheet > total Liabilities
33774000
Quarters > 2 > balance Sheet > equity
23705000
Quarters > 2 > cash Flow > net Income
-13144000
Quarters > 2 > cash Flow > depreciation
666000
Quarters > 2 > cash Flow > change In Working Capital
-2138000
Quarters > 2 > cash Flow > cash From Operations
-13184000
Quarters > 2 > cash Flow > capital Expenditures
127000
Quarters > 2 > cash Flow > cash From Investing
-6099000
Quarters > 2 > cash Flow > cash From Financing
-379000
Quarters > 2 > cash Flow > net Change In Cash
-19662000
Quarters > 2 > ratios > PE
-0.10371890137278535
Quarters > 2 > ratios > PB
0.0016039247078675385
Quarters > 2 > ratios > ROE
-55.4524361948956
Quarters > 2 > ratios > ROA
-22.86922180274535
Quarters > 2 > ratios > FCF
-13311000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
512000
Quarters > 3 > income Statement > gross Profit
-512000
Quarters > 3 > income Statement > operating Expenses
14427000
Quarters > 3 > income Statement > operating Income
-14427000
Quarters > 3 > income Statement > interest Expense
146000
Quarters > 3 > income Statement > pretax Income
-13977000
Quarters > 3 > income Statement > net Income
-13977000
Quarters > 3 > income Statement > eps
-0.11050628219556889
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
126481497
Quarters > 3 > income Statement > income Tax Expense
146000
Quarters > 3 > income Statement > EBITDA
-13305000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
450000
Quarters > 3 > balance Sheet > cash
37058000
Quarters > 3 > balance Sheet > short Term Investments
18790000
Quarters > 3 > balance Sheet > receivables
407000
Quarters > 3 > balance Sheet > inventories
2747000
Quarters > 3 > balance Sheet > total Current Assets
59705000
Quarters > 3 > balance Sheet > property Plant Equipment
11662000
Quarters > 3 > balance Sheet > total Assets
71367000
Quarters > 3 > balance Sheet > payables
1893000
Quarters > 3 > balance Sheet > short Term Debt
1392000
Quarters > 3 > balance Sheet > long Term Debt
12339000
Quarters > 3 > balance Sheet > total Liabilities
36355000
Quarters > 3 > balance Sheet > equity
35012000
Quarters > 3 > cash Flow > net Income
-13977000
Quarters > 3 > cash Flow > depreciation
526000
Quarters > 3 > cash Flow > change In Working Capital
-687000
Quarters > 3 > cash Flow > cash From Operations
-12158000
Quarters > 3 > cash Flow > capital Expenditures
90000
Quarters > 3 > cash Flow > cash From Investing
26610000
Quarters > 3 > cash Flow > cash From Financing
126000
Quarters > 3 > cash Flow > net Change In Cash
14578000
Quarters > 3 > ratios > PE
-0.11050628219556889
Quarters > 3 > ratios > PB
0.0010837555438135496
Quarters > 3 > ratios > ROE
-39.920598651890785
Quarters > 3 > ratios > ROA
-19.584681995880448
Quarters > 3 > ratios > FCF
-12248000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2234000
Annuals > 0 > income Statement > gross Profit
-2234000
Annuals > 0 > income Statement > operating Expenses
56051000
Annuals > 0 > income Statement > operating Income
-58285000
Annuals > 0 > income Statement > interest Expense
696000
Annuals > 0 > income Statement > pretax Income
-56934
Annuals > 0 > income Statement > net Income
-56934
Annuals > 0 > income Statement > eps
-0.00045004268504758593
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
126508000
Annuals > 0 > income Statement > income Tax Expense
-56934
Annuals > 0 > income Statement > EBITDA
-54004000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1351000
Annuals > 0 > balance Sheet > cash
4931000
Annuals > 0 > balance Sheet > short Term Investments
25464000
Annuals > 0 > balance Sheet > receivables
414000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
33230000
Annuals > 0 > balance Sheet > property Plant Equipment
11081000
Annuals > 0 > balance Sheet > total Assets
44311000
Annuals > 0 > balance Sheet > payables
1783000
Annuals > 0 > balance Sheet > short Term Debt
1906000
Annuals > 0 > balance Sheet > long Term Debt
13262000
Annuals > 0 > balance Sheet > total Liabilities
30902000
Annuals > 0 > balance Sheet > equity
13409000
Annuals > 0 > cash Flow > net Income
-56934000
Annuals > 0 > cash Flow > depreciation
2234000
Annuals > 0 > cash Flow > change In Working Capital
-8543000
Annuals > 0 > cash Flow > cash From Operations
-57238000
Annuals > 0 > cash Flow > capital Expenditures
803000
Annuals > 0 > cash Flow > cash From Investing
28844000
Annuals > 0 > cash Flow > cash From Financing
-1140000
Annuals > 0 > cash Flow > net Change In Cash
-29534000
Annuals > 0 > ratios > PE
-0.00045004268504758593
Annuals > 0 > ratios > PB
0.0018869117756730555
Annuals > 0 > ratios > ROE
-0.42459542098590497
Annuals > 0 > ratios > ROA
-0.1284872830674099
Annuals > 0 > ratios > FCF
-58041000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
20
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
-1000
Annuals > 1 > income Statement > cost Of Revenue
1684000
Annuals > 1 > income Statement > gross Profit
-1684000
Annuals > 1 > income Statement > operating Expenses
74295000
Annuals > 1 > income Statement > operating Income
-75979000
Annuals > 1 > income Statement > interest Expense
514000
Annuals > 1 > income Statement > pretax Income
-75222000
Annuals > 1 > income Statement > net Income
-75210000
Annuals > 1 > income Statement > eps
-0.5971936424802315
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
125939050
Annuals > 1 > income Statement > income Tax Expense
-12000
Annuals > 1 > income Statement > EBITDA
-73024000
Annuals > 1 > income Statement > operating Margin
7597900
Annuals > 1 > income Statement > total Other Income Expense Net
757000
Annuals > 1 > balance Sheet > cash
33475000
Annuals > 1 > balance Sheet > short Term Investments
53352000
Annuals > 1 > balance Sheet > receivables
414000
Annuals > 1 > balance Sheet > inventories
6124000
Annuals > 1 > balance Sheet > total Current Assets
93887000
Annuals > 1 > balance Sheet > property Plant Equipment
12512000
Annuals > 1 > balance Sheet > total Assets
106399000
Annuals > 1 > balance Sheet > payables
5295000
Annuals > 1 > balance Sheet > short Term Debt
1504000
Annuals > 1 > balance Sheet > long Term Debt
9933000
Annuals > 1 > balance Sheet > total Liabilities
44222000
Annuals > 1 > balance Sheet > equity
62177000
Annuals > 1 > cash Flow > net Income
-75222000
Annuals > 1 > cash Flow > depreciation
1684000
Annuals > 1 > cash Flow > change In Working Capital
9822000
Annuals > 1 > cash Flow > cash From Operations
-55928000
Annuals > 1 > cash Flow > capital Expenditures
1866000
Annuals > 1 > cash Flow > cash From Investing
-54392000
Annuals > 1 > cash Flow > cash From Financing
-167000
Annuals > 1 > cash Flow > net Change In Cash
-110487000
Annuals > 1 > ratios > PE
-0.5971936424802315
Annuals > 1 > ratios > PB
0.00040509850909500303
Annuals > 1 > ratios > ROE
-120.961127104878
Annuals > 1 > ratios > ROA
-70.68675457476104
Annuals > 1 > ratios > FCF
-57794000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
57794
Annuals > 1 > health Score
47
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
66000
Annuals > 2 > income Statement > cost Of Revenue
1937000
Annuals > 2 > income Statement > gross Profit
-1871000
Annuals > 2 > income Statement > operating Expenses
123204000
Annuals > 2 > income Statement > operating Income
-125075000
Annuals > 2 > income Statement > interest Expense
840000
Annuals > 2 > income Statement > pretax Income
-137175000
Annuals > 2 > income Statement > net Income
-137175000
Annuals > 2 > income Statement > eps
-1.0939673405271553
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
125392226
Annuals > 2 > income Statement > income Tax Expense
840000
Annuals > 2 > income Statement > EBITDA
-135233000
Annuals > 2 > income Statement > operating Margin
-189507.57575757575
Annuals > 2 > income Statement > total Other Income Expense Net
-12100000
Annuals > 2 > balance Sheet > cash
144885000
Annuals > 2 > balance Sheet > short Term Investments
869000
Annuals > 2 > balance Sheet > receivables
393000
Annuals > 2 > balance Sheet > inventories
8510000
Annuals > 2 > balance Sheet > total Current Assets
154129000
Annuals > 2 > balance Sheet > property Plant Equipment
12372000
Annuals > 2 > balance Sheet > total Assets
166673000
Annuals > 2 > balance Sheet > payables
3192000
Annuals > 2 > balance Sheet > short Term Debt
376000
Annuals > 2 > balance Sheet > long Term Debt
10323000
Annuals > 2 > balance Sheet > total Liabilities
38054000
Annuals > 2 > balance Sheet > equity
128619000
Annuals > 2 > cash Flow > net Income
-137175000
Annuals > 2 > cash Flow > depreciation
1102000
Annuals > 2 > cash Flow > change In Working Capital
12884000
Annuals > 2 > cash Flow > cash From Operations
-80990000
Annuals > 2 > cash Flow > capital Expenditures
1318000
Annuals > 2 > cash Flow > cash From Investing
-1318000
Annuals > 2 > cash Flow > cash From Financing
196167000
Annuals > 2 > cash Flow > net Change In Cash
113859000
Annuals > 2 > ratios > PE
-1.0939673405271553
Annuals > 2 > ratios > PB
0.00019498243027857472
Annuals > 2 > ratios > ROE
-106.65220535068691
Annuals > 2 > ratios > ROA
-82.3018725288439
Annuals > 2 > ratios > FCF
-82308000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1247.090909090909
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
557000
Annuals > 3 > income Statement > cost Of Revenue
52000
Annuals > 3 > income Statement > gross Profit
505000
Annuals > 3 > income Statement > operating Expenses
32787000
Annuals > 3 > income Statement > operating Income
-32282000
Annuals > 3 > income Statement > interest Expense
1181000
Annuals > 3 > income Statement > pretax Income
-39957000
Annuals > 3 > income Statement > net Income
-39957000
Annuals > 3 > income Statement > eps
-0.31850129775110203
Annuals > 3 > income Statement > dividends Per Share
59814000
Annuals > 3 > income Statement > shares Outstanding
125453178
Annuals > 3 > income Statement > income Tax Expense
-4580000
Annuals > 3 > income Statement > EBITDA
-38058000
Annuals > 3 > income Statement > operating Margin
-5795.691202872531
Annuals > 3 > income Statement > total Other Income Expense Net
-7675000
Annuals > 3 > balance Sheet > cash
31143000
Annuals > 3 > balance Sheet > short Term Investments
10000
Annuals > 3 > balance Sheet > receivables
387000
Annuals > 3 > balance Sheet > inventories
3312000
Annuals > 3 > balance Sheet > total Current Assets
35674000
Annuals > 3 > balance Sheet > property Plant Equipment
12158000
Annuals > 3 > balance Sheet > total Assets
50141000
Annuals > 3 > balance Sheet > payables
9021000
Annuals > 3 > balance Sheet > short Term Debt
27593000
Annuals > 3 > balance Sheet > long Term Debt
10699000
Annuals > 3 > balance Sheet > total Liabilities
137516000
Annuals > 3 > balance Sheet > equity
-87375000
Annuals > 3 > cash Flow > net Income
-39957000
Annuals > 3 > cash Flow > depreciation
717000
Annuals > 3 > cash Flow > change In Working Capital
-2791000
Annuals > 3 > cash Flow > cash From Operations
-33910000
Annuals > 3 > cash Flow > capital Expenditures
1477000
Annuals > 3 > cash Flow > cash From Investing
-1477000
Annuals > 3 > cash Flow > cash From Financing
66109000
Annuals > 3 > cash Flow > net Change In Cash
30722000
Annuals > 3 > ratios > PE
-0.31850129775110203
Annuals > 3 > ratios > PB
-0.0002871603502145923
Annuals > 3 > ratios > ROE
45.730472103004296
Annuals > 3 > ratios > ROA
-79.68927624100039
Annuals > 3 > ratios > FCF
-35387000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-63.53141831238779
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.08954707667154019
Valuation > metrics > PB
0.0028462525169662164
Valuation > final Score
70
Valuation > verdict
99.7% Undervalued
Profitability > metrics > ROE
-84.95786412111268
Profitability > metrics > ROA
-34.28227505266326
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.3045715564173315
Risk > metrics > Interest Coverage
-64.01098901098901
Risk > final Score
-238
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.00786120899973
Liquidity > metrics > Quick Ratio
9.00786120899973
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-238
Prev Risks > 1
-276
Prev Risks > 2
-365
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:22:43.652Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-01
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.09
Earnings History > 2 > eps Estimate
-0.08
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-12.5
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-29
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
-0.1
Earnings History > 3 > eps Difference
0.1
Earnings History > 3 > surprise Percent
100
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-08-08
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-0.1
Earnings History > 4 > eps Difference
0.1
Earnings History > 4 > surprise Percent
100
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-07
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-0.1
Earnings History > 5 > eps Difference
0.1
Earnings History > 5 > surprise Percent
100
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2024-03-27
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0899
Earnings History > 6 > eps Estimate
-0.1
Earnings History > 6 > eps Difference
0.0101
Earnings History > 6 > surprise Percent
10.1
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-11-08
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1
Earnings History > 7 > eps Estimate
-0.12
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
16.6667
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-08-09
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.11
Earnings History > 8 > eps Estimate
-0.15
Earnings History > 8 > eps Difference
0.04
Earnings History > 8 > surprise Percent
26.6667
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-05-09
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.15
Earnings History > 9 > eps Estimate
-0.16
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
6.25
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2023-03-27
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.16
Earnings History > 10 > eps Estimate
-0.16
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-11-10
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.15
Earnings History > 11 > eps Estimate
-0.15
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-08-11
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.14
Earnings History > 12 > eps Estimate
-0.35
Earnings History > 12 > eps Difference
0.21
Earnings History > 12 > surprise Percent
60
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-05-09
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.15
Earnings History > 13 > eps Estimate
-0.36
Earnings History > 13 > eps Difference
0.21
Earnings History > 13 > surprise Percent
58.3333
Earnings History > 14 > period
2021-12-31
Earnings History > 14 > report Date
2022-03-24
Earnings History > 14 > date
2021-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.19
Earnings History > 14 > eps Estimate
-0.36
Earnings History > 14 > eps Difference
0.17
Earnings History > 14 > surprise Percent
47.2222
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-12-23
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.24
Earnings History > 15 > eps Estimate
-0.13
Earnings History > 15 > eps Difference
-0.11
Earnings History > 15 > surprise Percent
-84.6154
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-09-30
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.4422
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.4422
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-06-30
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.3917
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.3917
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-12-31
Earnings History > 18 > report Date
2021-03-31
Earnings History > 18 > date
2020-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.4622
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.4622
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-09-30
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.2416
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.2416
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-06-30
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.1301
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.1301
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.1062
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.1062
Earnings History > 21 > surprise Percent
-
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AScientists discover how Covid shots cause deadly heart damage... as officials launch probe into vaccine-linked deaths Daily Mail
Read more →Showing 2 of 10
(Last Updated 2024-03-31)
Rating:
STRONG BUY
Target Price:
$15
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2024-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 15.11% of the total shares of Vaxxinity Inc
1.
Adage Capital Partners Gp LLC(2.3669%)
since
2023/12/31
2.
BlackRock Inc(2.1412%)
since
2023/12/31
3.
Vanguard Group Inc(1.8863%)
since
2023/12/31
4.
Vanguard Total Stock Mkt Idx Inv(1.1746%)
since
2024/04/30
5.
Prime Movers Lab LLC(0.9483%)
since
2023/12/31
6.
iShares Russell 2000 ETF(0.7833%)
since
2024/04/30
7.
Geode Capital Management, LLC(0.6643%)
since
2023/12/31
8.
State Street Corporation(0.6306%)
since
2023/12/31
9.
Vanguard Institutional Extnd Mkt Idx Tr(0.4434%)
since
2024/04/30
10.
Fidelity Small Cap Index(0.3094%)
since
2024/02/29
11.
Bank of America Corp(0.2827%)
since
2023/12/31
12.
iShares Russell 2000 Growth ETF(0.2781%)
since
2024/04/30
13.
Northern Trust Corp(0.2639%)
since
2023/12/31
14.
State St Russell Sm/Mid Cp® Indx NL Cl C(0.262%)
since
2024/04/30
15.
Creative Planning Inc(0.2249%)
since
2023/12/31
16.
Morgan Stanley - Brokerage Accounts(0.1819%)
since
2023/12/31
17.
Bridgeway Capital Management, LLC(0.1808%)
since
2023/12/31
18.
Bridgeway Ultra-Small Company Market(0.1709%)
since
2024/03/31
19.
Fidelity Extended Market Index(0.1674%)
since
2024/03/31
20.
Vanguard Russell 2000 ETF(0.1252%)
since
2024/04/30
21.
Pathstone Holdings LLC(0.1214%)
since
2023/12/31
22.
Pathstone Family Office, LLC(0.1214%)
since
2023/09/30
23.
SCOGGIN LLC(0.1183%)
since
2023/09/30
24.
NT R2000 Growth Index Fund - NL(0.1009%)
since
2023/12/31
25.
NT R2000 Index Fund - NL(0.0969%)
since
2024/03/31
26.
Bank of New York Mellon Corp(0.0952%)
since
2023/12/31
27.
Charles Schwab Investment Management Inc(0.0949%)
since
2023/12/31
28.
BlackRock Extended Mkt Composite(0.0912%)
since
2023/09/30
29.
BlackRock Extended Equity Market K(0.0787%)
since
2024/03/31
30.
NT R2000 Index Fund - DC - NL - 2(0.0769%)
since
2024/03/31
31.
Schwab Small Cap Index(0.0768%)
since
2024/04/30
32.
iShares Micro-Cap ETF(0.072%)
since
2024/04/30
33.
Northern Trust Russell 2000 Growth Index(0.0672%)
since
2024/03/31
34.
NT R2000 Growth Index Fund - L(0.0672%)
since
2023/12/31
35.
IEQ CAPITAL, LLC(0.0657%)
since
2023/12/31
36.
BlackRock Russell 2500â„¢ Index F(0.0628%)
since
2024/03/31
37.
iShares Russell 2000 Small-Cap Idx Instl(0.0627%)
since
2024/03/31
38.
McAdam, LLC(0.0618%)
since
2024/03/31
39.
Barclays PLC(0.0461%)
since
2023/12/31
40.
Nuveen Asset Management, LLC(0.0458%)
since
2023/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
null%
(Last Updated 2024-03-31)
(Last Updated 2024-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.